Li PK - Search Results

1

Novel pyrrolopyrimidines as Mps1/TTK kinase inhibitors for breast cancer.

Sugimoto Y, Sawant DB, Fisk HA, Mao L, Li C, Chettiar S, Li PK, Darby MV, Brueggemeier RW. Sugimoto Y, et al. Among authors: li c, li pk. Bioorg Med Chem. 2017 Apr 1;25(7):2156-2166. doi: 10.1016/j.bmc.2017.02.030. Epub 2017 Feb 16. Bioorg Med Chem. 2017. PMID: 28259529

2

Structure-activity relationships studies of the anti-angiogenic activities of linomide.

Shi J, Xiao Z, Ihnat MA, Kamat C, Pandit B, Hu Z, Li PK. Shi J, et al. Among authors: li pk. Bioorg Med Chem Lett. 2003 Mar 24;13(6):1187-9. doi: 10.1016/s0960-894x(03)00047-7. Bioorg Med Chem Lett. 2003. PMID: 12643940

3

Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer.

Brueggemeier RW, Díaz-Cruz ES, Li PK, Sugimoto Y, Lin YC, Shapiro CL. Brueggemeier RW, et al. Among authors: li pk. J Steroid Biochem Mol Biol. 2005 May;95(1-5):129-36. doi: 10.1016/j.jsbmb.2005.04.013. J Steroid Biochem Mol Biol. 2005. PMID: 15964185

4

Conformationally restricted analogs of Combretastatin A-4 derived from SU5416.

Li PK, Xiao Z, Hu Z, Pandit B, Sun Y, Sackett DL, Werbovetz K, Lewis A, Johnsamuel J. Li PK, et al. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5382-5. doi: 10.1016/j.bmcl.2005.09.001. Epub 2005 Oct 6. Bioorg Med Chem Lett. 2005. PMID: 16213720

5

A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities.

Li PK, Pandit B, Sackett DL, Hu Z, Zink J, Zhi J, Freeman D, Robey RW, Werbovetz K, Lewis A, Li C. Li PK, et al. Among authors: li c. Mol Cancer Ther. 2006 Feb;5(2):450-6. doi: 10.1158/1535-7163.MCT-05-0254. Mol Cancer Ther. 2006. PMID: 16505120

6

Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416.

Pandit B, Sun Y, Chen P, Sackett DL, Hu Z, Rich W, Li C, Lewis A, Schaefer K, Li PK. Pandit B, et al. Among authors: li c, li pk. Bioorg Med Chem. 2006 Oct 1;14(19):6492-501. doi: 10.1016/j.bmc.2006.06.017. Epub 2006 Jul 24. Bioorg Med Chem. 2006. PMID: 16860559

7

Inhibitors of NF-kappaB derived from thalidomide.

de-Blanco EJ, Pandit B, Hu Z, Shi J, Lewis A, Li PK. de-Blanco EJ, et al. Among authors: li pk. Bioorg Med Chem Lett. 2007 Nov 1;17(21):6031-5. doi: 10.1016/j.bmcl.2007.01.088. Epub 2007 Feb 2. Bioorg Med Chem Lett. 2007. PMID: 17845850

8

Design, synthesis, and studies of small molecule STAT3 inhibitors.

Bhasin D, Cisek K, Pandharkar T, Regan N, Li C, Pandit B, Lin J, Li PK. Bhasin D, et al. Among authors: li c, li pk. Bioorg Med Chem Lett. 2008 Jan 1;18(1):391-5. doi: 10.1016/j.bmcl.2007.10.031. Epub 2007 Oct 17. Bioorg Med Chem Lett. 2008. PMID: 18006313

9

Development of keratinocyte growth factor receptor tyrosine kinase inhibitors for the treatment of cancer.

Hackett J, Xiao Z, Zang XP, Lerner ML, Brackett DJ, Brueggemeier RW, Li PK, Pento JT. Hackett J, et al. Among authors: li pk. Anticancer Res. 2007 Nov-Dec;27(6B):3801-6. Anticancer Res. 2007. PMID: 18225535 Free article.

10

Curcumin is a potent DNA hypomethylation agent.

Liu Z, Xie Z, Jones W, Pavlovicz RE, Liu S, Yu J, Li PK, Lin J, Fuchs JR, Marcucci G, Li C, Chan KK. Liu Z, et al. Among authors: li c, li pk. Bioorg Med Chem Lett. 2009 Feb 1;19(3):706-9. doi: 10.1016/j.bmcl.2008.12.041. Epub 2008 Dec 14. Bioorg Med Chem Lett. 2009. PMID: 19112019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

786 results

Search Page